interferoninduc
transmembran
protein
recent
identifi
potent
antivir
effector
function
suppress
entri
broad
rang
envelop
virus
modul
cellular
tropism
independ
viral
receptor
express
howev
antivir
effect
mechan
ifitm
respons
viral
infect
remain
incomplet
understood
character
work
focus
investig
function
extracellular
protein
cell
model
infect
found
contribut
baselin
interferoninduc
inhibit
denv
entri
importantli
studi
first
time
demonstr
presenc
ifitmcontain
exosom
extracellular
environ
identifi
abil
cellular
exosom
intercellularli
deliv
thu
transmit
antivir
effect
infect
noninfect
cell
thu
find
provid
new
insight
basic
mechan
underli
action
might
lead
futur
develop
exosomemedi
antivir
strategi
use
therapeut
agent
conceiv
variat
basal
induc
level
ifitm
well
intracellular
extracellular
level
ifitm
might
predict
sever
dengu
viru
infect
among
individu
across
speci
dengu
viru
envelop
singlestrand
posit
strand
viru
belong
flaviviru
genu
famili
flavivirida
four
relat
distinct
serotyp
halstead
simmon
et
al
denv
aetiolog
agent
dengu
fever
df
preval
arthropodborn
viral
diseas
human
million
case
worldwid
annual
denv
transmit
mosquito
aed
aegypti
aed
albopictu
tropic
subtrop
region
mosquito
endem
place
billion
peopl
risk
infect
global
guzman
et
al
simmon
et
al
note
infect
individu
develop
sever
often
lethal
syndrom
design
dengu
haemorrhag
fever
dhf
dengu
shock
syndrom
dss
children
bear
diseas
burden
guzman
et
al
genotyp
differ
denv
indic
associ
variat
viral
virul
heterotyp
dengu
viru
antibodi
believ
risk
factor
develop
dhf
dss
secondari
infect
guzman
et
al
despit
formid
toll
impos
denv
world
health
approv
vaccin
effect
specif
antidenv
therapi
current
avail
denv
infect
halstead
guzman
et
al
major
host
defenc
system
viral
infect
interferon
ifn
famili
notabl
ifnalpha
ifnbeta
initi
potent
antivir
respons
activ
innat
immun
mediat
induct
ifnstimul
gene
isg
lead
establish
antivir
state
sadler
william
ifn
induc
transmembran
protein
recent
identifi
antivir
mediat
induc
ifn
confer
host
cell
resist
varieti
pathogen
virus
influenza
viru
iav
brass
et
al
feeley
et
al
huang
et
al
everitt
et
al
west
nile
viru
brass
et
al
jiang
et
al
denv
brass
et
al
jiang
et
al
chan
et
al
vesicular
stomat
viru
marburg
viru
huang
et
al
ebola
viru
huang
et
al
sar
coronaviru
huang
et
al
human
immunodefici
viru
lu
et
al
hepat
c
viru
yao
et
al
mechanist
ifitm
known
isg
product
act
restrict
entri
step
viral
infect
process
feeley
et
al
particular
brass
et
al
demonstr
action
singl
intrins
immun
effector
profoundli
effect
essenti
barrier
iav
infect
vitro
knockout
mous
model
human
block
viruscellular
membran
fusion
thu
prevent
cytosol
entri
viru
brass
et
al
feeley
et
al
everitt
et
al
interestingli
anoth
studi
reveal
ifitm
protein
could
interfer
antibodydepend
enhanc
ade
effect
secondari
dengu
viru
infect
bypass
ifnmedi
restrict
chan
et
al
taken
togeth
previou
studi
defin
mediat
requir
antivir
action
ifn
repres
key
compon
human
antivir
defenc
system
probabl
target
earli
step
viral
infect
open
question
howev
remain
concern
detail
biolog
function
ifitm
ifntrigg
cascad
precis
mechan
host
cellular
defenc
system
involv
ifitm
activ
respons
viral
infect
knowledg
provid
insight
design
new
antivir
therapeut
use
ifitm
protein
furthermor
worth
note
secret
membranebound
protein
particular
interest
drug
develop
extracellular
natur
render
access
therapeut
intervent
novel
altern
secret
system
exosom
small
vesicl
nm
diamet
endocyt
origin
releas
cell
extracellular
environ
normal
patholog
condit
theri
et
al
exosom
form
inward
bud
late
endosom
membran
give
rise
intracellular
multivesicular
bodi
mvb
involv
fusion
plasma
membran
releas
mvb
extracellular
environ
exosom
theri
et
al
prior
work
focus
exosom
new
famili
member
bioactiv
vesicl
function
promot
intercellular
commun
shuttl
protein
lipid
rna
cell
particip
variou
biolog
process
includ
immunomodulatori
event
schorey
bhatnagar
shuttl
compon
pathogen
microb
exosom
could
stimul
immun
respons
instanc
exosom
isol
cell
infect
mycobacterium
tuberculosi
shown
contain
bacteri
compon
promot
antigen
present
macrophag
activ
bhatnagar
schorey
bhatnagar
et
al
moreov
exosom
may
also
promot
intercellular
spread
infecti
cargo
observ
celltocel
transmiss
hiv
gould
et
al
izquierdousero
et
al
hand
despit
advanc
understand
function
exosom
physiolog
signific
exosom
shuttl
bioactiv
molecul
key
host
defenc
system
remain
enigmat
recent
atanu
et
al
demonstr
belong
isg
famili
cellular
cytidin
deaminas
effect
restrict
replic
varieti
exogen
retrovirus
export
exosom
confer
antivir
phenotyp
recipi
cell
khatua
et
al
li
et
al
propos
antivir
mechan
activ
involv
induct
intercellular
transfer
antivir
molecul
protein
protein
mrna
mrna
etc
liver
nonparenchym
cell
hepatocyt
via
exosom
use
hbv
infect
model
also
observ
similar
exosomemedi
transfer
mrna
macrophag
cell
indepth
studi
whether
antihbv
activ
depend
independ
exosomemedi
transfer
mrna
therefor
tempt
hypothes
direct
exchang
isg
protein
transfer
exosom
among
host
cell
might
contribut
establish
antivir
state
uninfect
cell
addit
direct
action
ifn
stimul
studi
focus
investig
function
extracellular
protein
cell
model
infect
found
endogen
basal
protein
level
ifitm
invers
correl
infect
induct
ifitm
cell
low
basal
protein
level
suffici
drive
protect
host
cell
infect
entri
convers
loss
ifitm
host
cell
pronouncedli
enhanc
infect
importantli
studi
first
time
demonstr
presenc
ifitmcontain
exosom
extracellular
environ
function
exosom
vehicl
intercellular
transmiss
antivir
protein
effort
investig
whether
endogen
host
cell
play
role
interact
denv
host
cell
first
compar
express
denvpermiss
cell
line
versu
without
infect
notabl
follow
infect
multipl
infect
moi
human
cell
line
permiss
replic
express
found
induc
infect
variou
cell
line
demonstr
western
blot
analysi
fig
next
analys
correl
level
cell
line
infect
found
endogen
express
vari
differ
cell
line
cell
express
low
level
protein
suscept
infect
fig
exponenti
regress
analysi
show
level
protein
host
cell
invers
correl
suscept
infect
significantli
r
p
n
fig
suggest
might
import
cellular
restrict
factor
denv
infect
evalu
role
ifitm
protein
denv
infect
gener
perman
cell
line
stabli
overexpress
human
ifitm
control
vector
respect
hela
cell
fig
c
show
fig
overexpress
drastic
diminish
number
cell
indic
twofold
fourfold
reduct
viral
e
protein
accumul
viral
infect
hela
cell
similar
profound
restrict
also
seen
transient
transduc
despit
lesser
extent
overexpress
fig
f
demonstr
potenc
confer
host
cell
resist
denv
infect
next
examin
effect
entri
step
found
entri
reduc
approxim
twofold
fig
control
monoclon
neutral
antibodi
demonstr
success
entri
blockag
suggest
disrupt
denv
replic
associ
target
abrog
viral
entri
sinc
ifn
stimul
signal
play
pivot
role
protect
cell
viral
infect
damag
investig
function
signific
ifnmedi
antidenv
respons
shown
fig
b
compar
huvec
cell
transfect
control
scrambl
sirna
transfect
effici
deplet
basallevel
express
increas
permiss
transfect
cell
infect
indic
increas
infect
huvec
constitut
express
high
basal
level
endogen
express
similar
effect
deplet
reproduc
anoth
cell
model
basal
level
low
greatli
induc
sirna
silenc
markedli
attenu
protect
effect
infect
hela
cell
lead
profoundli
increas
infect
presenc
fig
indic
deplet
could
decreas
antivir
action
also
perform
denv
bindingentri
assay
follow
knockdown
express
result
show
effect
sirna
silenc
bind
hela
cell
penetr
cell
significantli
promot
deplet
fig
thu
result
suggest
involv
mediat
ifninduc
cellular
respons
denv
infect
attempt
analys
biochem
properti
found
protein
present
intracelluarli
extracellularli
specif
cell
cultur
supernat
collect
parent
huvec
cell
cell
express
high
basal
level
endogen
huvec
cell
transfect
huvec
cell
transfect
nontarget
control
sirna
huvecsinc
cell
transfect
cell
transfect
construct
h
supernat
deriv
group
differ
treatment
collect
centrifug
g
min
g
min
remov
cell
cell
debri
follow
filtrat
filter
supernat
concentr
use
amicon
centrifug
filter
unit
kda
cutoff
valu
subject
western
blot
analysi
use
antiifitm
antibodi
data
show
protein
present
cytosol
cultur
medium
fig
suggest
possibl
could
releas
extracellular
space
also
noteworthi
express
antivir
effect
mediat
exosom
supernat
collect
cultur
huvec
cell
lost
knock
exosom
secret
inhibit
exosomereleas
inhibitor
fig
amino
acid
sequenc
contain
put
signal
peptid
protein
secret
sought
explor
possibl
export
could
exosomemedi
ad
cell
cultur
supernat
huvec
cell
transfect
huvec
transfect
nontarget
control
sirna
huvecsinc
cell
transfect
cell
transfect
construct
h
collect
concentr
sdspage
immunoblot
use
antibodi
cell
lysat
posit
control
e
electron
micrograph
crude
exosom
neg
stain
uranyl
acet
examin
kv
shown
f
purifi
exosom
deriv
group
cell
describ
analys
immunoblot
anticalnexin
endoplasm
reticulum
er
marker
golgi
marker
antibodi
identifi
exosom
deriv
group
cell
indic
mechan
achiev
exosom
prepar
cultur
media
huvec
huvecsinc
cell
cell
cell
cell
cell
cell
subject
sucros
gradient
ultracentrifug
electron
microscop
examin
exosom
reveal
vesicl
rang
size
nm
nm
fig
interestingli
detect
exosom
purifi
cultur
supernat
huvec
huvecsinc
cell
also
abund
produc
cell
contrari
howev
exosom
isol
cell
cell
cell
contain
detect
fig
purifi
exosom
character
presenc
convent
marker
exsosom
name
nonexosom
marker
calnexin
endoplasm
reticulum
marker
golgi
matrix
marker
use
western
blot
analysi
shown
fig
exosom
collect
group
shown
posit
neg
calnexin
verifi
contamin
subcellular
fraction
purifi
exosom
prepar
protein
contain
exosom
composit
verifi
mass
spectrometri
fig
togeth
data
demonstr
secret
exosom
limit
huvec
express
high
level
endogen
also
cell
undergo
ifn
stimul
transient
express
exogen
find
contain
exosom
export
cell
express
prompt
us
investig
whether
exosom
intern
cell
system
antidenv
activ
transfer
recipi
cell
studi
test
possibl
incub
hela
cell
express
lowlevel
exosom
collect
huvec
huvecsinc
cell
inde
shown
fig
increas
abund
detect
recipi
hela
cell
treat
huvec
cell
cellderiv
exosom
ml
cell
moreov
detect
protein
lysat
recipi
hela
cell
treat
exosom
deriv
huvec
cell
determin
immunoblot
doseand
timedepend
fig
notabl
report
exosom
might
capabl
deliv
exogen
small
rna
sirna
microrna
vitro
vivo
van
den
boorn
et
al
pan
et
al
shtam
et
al
experi
preform
protein
transfer
assay
recipi
hela
cell
transfect
rule
potenti
sideeffect
possibl
deliv
exosom
endogen
exosomedeliv
ifitm
mrna
recipi
cell
furthermor
shown
fig
increas
abund
detect
recipi
cell
treat
huvecsincderiv
exosom
timedepend
manner
treat
cellderiv
exosom
consist
western
blot
data
immunofluoresc
stain
confoc
microscop
analysi
show
local
cytoplasm
recipi
hela
cell
significantli
higher
follow
treatment
exosom
deriv
cell
fig
contrast
result
show
cellderiv
exosom
chang
express
recipi
hela
cell
compar
treatment
cellor
cellsderiv
exosom
fig
moreov
exosom
treatment
termin
h
incub
blank
cultur
media
total
length
h
increas
amount
endogen
within
recipi
hela
cell
fig
suggest
exosom
treatment
procedur
per
se
chang
endogen
express
recipi
hela
cell
addit
order
verifi
increas
protein
level
transfer
recipi
cell
due
exosom
transfer
rather
stimul
express
endogen
measur
mrna
level
cell
treat
use
quantit
realtim
rtpcr
found
treatment
induc
increas
endogen
mrna
hela
cell
fig
furthermor
evalu
halflif
cell
cultur
supernat
quantifi
protein
supernat
cultur
huvec
variou
time
point
h
use
western
blot
specif
supernat
deriv
huvec
cell
collect
centrifug
g
min
centrifug
g
min
remov
cell
cell
debri
follow
filtrat
filter
obtain
supernat
concentr
use
amicon
centrifug
filter
unit
kda
cutoff
valu
divid
group
incub
humidifi
atmospher
co
h
respect
subject
western
blot
analysi
use
antibodi
shown
fig
littl
chang
protein
intercellular
transfer
exosom
hela
cell
incub
purifi
ml
exosom
deriv
supernat
cultur
huvec
huvecsinc
cell
serumfre
media
h
incub
increas
amount
exosom
deriv
cell
h
c
incub
ml
deriv
cell
huvec
h
h
h
h
incub
ml
deriv
cell
h
follow
wash
exosom
h
treatment
f
indic
hela
cell
maintain
dmem
treatment
h
hela
cell
silenc
incub
ml
exosom
deriv
huvec
huvecsinc
b
cell
lysat
analys
immunoblot
protein
investig
whether
exosom
intern
recipi
cell
could
confer
resist
infect
hela
cell
cultur
serumfre
condit
expos
increas
amount
purifi
exosom
h
purifi
exosom
use
treat
hela
cell
simultan
infect
moi
h
post
infect
infect
cell
examin
realtim
rtpcr
assay
strikingli
infect
suppress
potent
exosom
dosedepend
manner
parent
hela
cell
fig
hela
cell
endogen
knock
fig
copi
number
viral
rna
reduc
cultur
supernat
fig
indic
observ
antivir
effect
mediat
exosometransf
also
perform
immunofluoresc
analysi
infect
hela
cell
treat
without
stain
deliv
denv
protein
e
shown
fig
result
show
denv
protein
e
present
cell
contain
data
cpe
reduct
assay
demonstr
exosom
also
attenu
cpe
trigger
infect
fig
moreov
result
show
effect
bind
host
cell
postentri
step
infect
penetr
cell
significantli
inhibit
exosom
reduct
approxim
fourfold
fig
contrast
control
exosom
prepar
cell
contain
vector
plasmid
without
express
cassett
exhibit
antidenv
activ
suggest
main
exosom
compon
respons
detect
antivir
activ
exosom
verifi
enhanc
antivir
effect
caus
transfer
result
action
rather
stimul
paracrin
ifn
respons
concentr
human
cultur
supernat
hela
cell
cell
treat
exosom
measur
elisa
use
sendai
viru
sev
hau
ml
posit
stimulu
control
result
show
treatment
chang
express
compar
controlexosom
fig
g
implic
reduct
viru
replic
due
nonspecif
effect
exosom
mediat
interferon
ifn
trigger
potent
antivir
respons
activ
host
innat
immun
lead
establish
cellular
antivir
state
mediat
induc
express
isg
accordingli
isg
repres
key
line
defenc
viral
infect
ifitm
among
potent
isg
product
broad
antivir
spectra
key
find
current
studi
name
transfer
intercellularli
via
extracellular
exosom
provid
new
insight
function
signific
ifninduc
antivir
protein
discoveri
role
free
ifitm
protein
ifitmladen
exosom
innat
cellular
defend
present
opportun
develop
exosomebas
tool
activ
combat
exist
emerg
pathogen
conceiv
variat
basal
induc
level
ifitm
well
intracellular
extracellular
level
ifitm
might
predict
sever
dengu
infect
among
individu
across
speci
exosom
secret
mani
type
cell
remain
stabl
variou
bodi
environ
transfer
protein
mrna
microrna
neighbour
distant
cell
exosom
contribut
modul
import
physiolog
patholog
process
immun
angiogenesi
cell
prolifer
cell
migrat
invas
celltocel
signal
schorey
bhatnagar
propos
novel
model
ifninduc
innat
immun
respons
infect
mediat
ifitmcontain
exosom
noteworthi
context
exosom
releas
ifntreat
cell
may
remot
commun
cell
mechan
antivir
phenotyp
transfer
exosom
recipi
cell
might
chanc
directli
stimul
ifn
interestingli
intercellular
commun
model
might
also
applic
explain
pioneer
observ
antiprolif
activ
transmit
ifnstimul
cell
nonstimul
cell
lloyd
et
al
subcellular
level
follow
ifn
induct
express
transfer
multivesicular
complex
assembl
exosom
vesicl
upon
transport
surfac
recipi
cell
fusion
mvc
plasma
membran
allow
assembl
ifitm
preexist
exosom
receptor
complex
unknown
thu
far
potenti
releas
exosom
particl
contain
ifitm
protein
travel
nonstimul
cell
receptor
assembl
also
occur
model
consist
find
antivir
state
transfer
ifn
induc
cell
nontreat
cell
cultur
hypothet
process
might
requir
ifitm
protein
process
reloc
host
cell
unknown
mechan
target
fig
antivir
activ
exosom
h
incub
exosom
hela
cell
parent
hela
cell
silenc
incub
viru
h
intracellular
c
extracellular
supernat
b
viral
rna
measur
realtim
rtpcr
assay
result
present
rel
ratio
total
cellular
rna
e
exosom
suppress
cpe
trigger
infect
intracellular
viral
rna
measur
realtim
rtpcr
assay
result
express
rel
fold
total
cellular
rna
condit
media
obtain
exosom
deriv
group
cell
treat
indic
quantit
measur
contain
e
f
protein
elisa
use
sendai
viru
sev
hau
ml
posit
stimulu
control
data
point
present
mean
sd
triplic
experi
student
twotail
test
perform
statist
signific
shown
asterisk
p
p
exosom
secret
interestingli
report
cytosol
protein
present
exosom
includ
member
rab
famili
involv
format
secret
exosom
rab
gdi
found
promot
exosom
dock
membran
fusion
event
theri
et
al
interest
feeley
et
al
report
primarili
resid
late
endosom
compart
partli
coloc
feeley
et
al
context
therefor
would
great
interest
investig
biogenesi
exosom
well
regul
might
provid
import
clue
rational
develop
optim
antivir
strategi
applic
ifn
highli
appreci
clinic
problem
associ
use
ifn
suboptim
efficaci
mani
virus
vari
degre
advers
effect
caus
ifn
treatment
remain
unsolv
borden
et
al
intens
effort
identifi
develop
new
endogen
antivir
factor
potenti
clinic
applic
isg
attract
candid
agent
therapeut
purpos
context
exosomecarri
discov
present
studi
appear
repres
novel
attract
potenti
antivir
strategi
natur
special
engin
exosom
serv
nanoshuttl
vehicl
drug
deliveri
anim
studi
test
feasibl
efficaci
appli
exosomebas
deliveri
antidenv
purpos
vivo
therefor
warrant
find
provid
first
set
evid
exist
extracellular
exosomepackag
form
enabl
antivir
activ
transmit
one
cell
anoth
lead
effici
establish
antivir
state
studi
deciph
structur
cell
biolog
basi
antivir
activ
ifitmexosom
theoret
well
practic
import
area
research
hela
cell
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
carlsbad
ca
supplement
fetal
bovin
serum
fb
hyclon
logan
ut
mm
lglutamin
ml
streptomycin
unit
ml
penicillin
invitrogen
human
umbil
endotheli
cell
huvec
grown
human
umbil
endotheli
cell
serumfre
medium
invitrogen
supplement
g
ml
endotheli
cell
growth
supplement
upstat
billerica
usa
cultur
maintain
humidifi
atmospher
aed
albopictu
cell
cultur
dmem
supplement
fb
u
ml
penicillin
mg
ml
streptomycin
strain
ngc
new
guinea
c
genbank
access
number
kindli
provid
guangzhou
center
diseas
control
prevent
cdc
tian
et
al
wu
et
al
propag
cell
line
briefli
monolay
cell
infect
moi
incub
day
supernat
harvest
centrifug
min
g
remov
pellet
cellular
debri
titr
determin
fac
assay
cell
previous
describ
lambeth
et
al
cell
harvest
lyse
sampl
buffer
contain
mm
trishcl
ph
mm
pmsf
glycerol
sd
mercaptoethanol
bromophenol
blue
sonic
protein
concentr
lysat
determin
use
bicinchonin
acid
protein
assay
kit
thermo
fisher
scientif
rockford
il
accord
manufactur
instruct
bsa
standard
protein
molecular
weight
standard
genstar
biosolut
co
ltd
beij
china
use
determin
molecular
weight
sampl
protein
aliquot
cell
lysat
contain
protein
subject
sdspage
transfer
pvdf
membran
follow
block
step
use
block
buffer
trisbuff
salin
tb
contain
nonfat
milk
h
room
temperatur
membran
incub
overnight
follow
specif
primari
antibodi
monoclon
monoclon
polyclon
proteintech
group
chicago
il
monoclon
antiflag
sigmaaldrich
st
loui
mo
e
mous
monoclon
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
monoclon
antiactin
sigmaaldrich
polyclon
santa
cruz
biotechnolog
antiflotillin
ctermin
sigmaaldrich
anticalnexin
proteintech
group
monoclon
cell
signal
danver
antibodi
incub
appropri
horseradish
peroxidas
hrp
conjug
secondari
antibodi
depend
primari
antibodi
use
perform
h
room
temperatur
membran
wash
three
time
trisbuff
salin
contain
min
incub
step
band
detect
use
enhanc
chemiluminesc
kit
thermo
fisher
scientif
kodak
film
actin
use
load
control
quantif
normal
intens
band
interest
pvdf
membran
quantit
calcul
quantiti
one
measur
softwar
biorad
hercul
ca
human
cdna
ctermin
ha
epitop
tag
amplifi
rtpcr
use
primer
shown
tabl
result
pcr
fragment
clone
pmscvpuro
vector
clontech
laboratori
inc
mountain
view
ca
bglii
ecori
site
gener
plasmid
respect
clone
cdna
sequenc
verifi
blank
pmscvpuro
vector
gener
use
control
construct
use
establish
stabli
transduc
cell
line
hela
cell
perman
express
ifitm
briefli
retrovir
particl
prepar
transfect
plasmid
dna
packag
cell
togeth
pik
plasmid
recombin
retrovir
particl
use
infect
hela
cell
stabli
transduc
cell
line
select
dmem
medium
supplement
puromycin
ml
transient
express
ifitm
protein
ifitm
gene
separ
subclon
pcdna
vector
invitrogen
kpni
bamhi
site
flagtag
sequenc
introduc
code
sequenc
cterminu
cell
transient
transfect
result
plasmid
pcdnaifitmsflag
standard
calcium
phosphat
coprecipit
method
hela
cell
transient
transfect
use
lipofectamin
invitrogen
follow
manufactur
instruct
small
interf
rna
sirna
duplex
whose
sequenc
provid
tabl
publish
previous
brass
et
al
purchas
ribobio
inc
guangzhou
guangdong
china
huvec
hela
cell
transfect
sirna
indic
concentr
use
lipofectamin
reagent
invitrogen
follow
manufactur
instruct
follow
treatment
u
ml
infect
moi
assess
express
ifitm
protein
cell
lysat
harvest
h
transfect
examin
western
blot
analysi
correspond
specif
antibodi
dengu
e
protein
detect
cell
infect
intracellular
stain
flow
cytometr
fcm
analysi
previous
describ
brass
et
al
chan
et
al
briefli
cell
growth
dmem
medium
seed
subsequ
cultur
h
follow
infect
moi
cell
harvest
indic
time
point
wash
cold
phosphatebuff
salin
pb
fix
paraformaldehyd
min
fix
cell
scrape
permeabil
methanol
incub
e
mous
monoclon
antibodi
santa
cruz
biotechnolog
appropri
fitcconjug
goat
antimous
igg
secondari
antibodi
santa
cruz
biotechnolog
fitcposit
cell
acquir
score
flow
cytometri
bectondickinson
counter
san
jose
ca
percentag
denvinfect
cell
defin
fitcposit
cell
distribut
fluoresc
dot
plot
use
cytometri
list
mode
data
acquisit
analysi
softwar
bectondickinson
counter
denv
cell
supernat
quantifi
determin
copi
number
viral
rna
use
quantit
realtim
rtpcr
previous
describ
mota
ricohess
cell
supernat
harvest
indic
time
point
total
rna
extract
use
qiaamp
minelut
viru
spin
kit
follow
instruct
manufactur
qiagen
chatsworth
ca
cdna
synthes
quantit
realtim
pcr
perform
standard
curv
analysi
use
realtim
pcr
detect
system
biorad
rel
quantif
result
present
ratio
rel
quantif
gapdh
primer
pair
use
shown
tabl
estim
denv
rna
copi
number
standard
curv
gener
use
vitrotranscrib
rna
standard
produc
follow
bp
fragment
ngc
strain
amplifi
rtpcr
clone
simpl
vector
takara
dalian
china
clone
plasmid
linear
ecorv
rna
transcript
gener
megascript
kit
ambion
accord
manufactur
instruct
concentr
transcrib
rna
determin
nanodrop
spectrophotomet
thermo
scientif
rockford
il
serial
dilut
prepar
use
construct
standard
curv
bind
entri
experi
perform
describ
previous
kanlaya
et
al
weidner
et
al
briefli
viru
bind
experi
cell
seed
plate
densiti
cell
per
well
cultur
h
follow
inocul
moi
incub
ice
h
allow
bind
imped
cell
entri
multipl
infect
ensur
least
cell
infect
minimum
one
infecti
viral
particl
unbound
viru
remov
cell
harvest
determin
amount
viral
rna
accumul
quantit
rtpcr
min
later
assess
viru
entri
cell
via
endocytosi
bind
ice
h
viru
inocula
remov
h
bind
ice
infect
cell
wash
pb
follow
incub
prewarm
dmem
min
initi
viru
cell
entri
subsequ
cell
rins
three
time
pb
treat
trypsin
min
wash
three
time
pb
remov
cellassoci
viru
enter
cytoplasm
assess
postentri
infect
step
viru
bind
entri
procedur
finish
hela
cell
subsequ
treat
control
exosom
total
cellular
rna
extract
measur
quantiti
viral
genom
enter
cell
use
realtim
rtpcr
assay
seven
group
cell
includ
huvec
high
basallevel
protein
nontarget
control
sirnatransfect
huvec
huvecsinc
huvec
cell
control
vectortransfect
cell
cell
u
ml
cell
cultur
medium
supplement
exosomefre
fb
overnight
centrifug
g
grown
monolay
confluenc
exosom
isol
cell
supernat
filtrat
step
differenti
ultracentrifug
previous
describ
khatua
et
al
briefli
supernat
deriv
huvec
cell
cultur
differ
treatment
collect
centrifug
g
min
g
min
remov
cell
cell
debri
follow
filtrat
filter
pall
life
scienc
port
washington
ny
ultracentrifug
g
h
pellet
crude
exosom
purif
crude
exosom
mix
ml
sucros
pb
place
bottom
optis
centrifug
tube
beckman
coulter
inc
munich
germani
overlaid
ml
sucros
ml
sucros
ultracentrifug
h
g
purifi
exosom
accumul
interfac
collect
wash
twice
dilut
pb
pellet
ultracentrifug
g
min
pellet
exosom
resuspend
pb
use
immedi
kept
sigmaaldrich
employ
inhibitor
exosom
secret
protein
concentr
exosom
prepar
determin
bicinchonin
acid
protein
assay
kit
thermo
fisher
scientif
accord
manufactur
instruct
use
bsa
standard
final
exosom
sampl
character
western
blot
analysi
protein
band
excis
gel
subject
mass
spectrometri
ms
analysi
accord
standard
procedur
khatua
et
al
purifi
exosom
process
neg
stain
analys
transmiss
electron
microscopi
tem
previous
describ
khatua
et
al
briefli
exosom
resuspend
pb
drop
onto
sheet
parafilm
formvarcarbon
coat
nickel
grid
float
min
room
temperatur
absorb
exosom
follow
wash
pb
twice
fix
paraformaldehyd
rins
pb
twice
grid
neg
stain
phosphotungst
acid
min
final
dri
sampl
view
use
tecnai
transmiss
electron
microscop
kv
store
grid
box
futur
work
cell
seed
plate
cell
per
well
h
prior
viral
infect
treatment
describ
evalu
antidenv
abil
purifi
exosom
ml
respect
ad
cultur
cell
incub
h
subsequ
mixtur
ngc
moi
ml
respect
preincub
h
ad
cell
three
wash
pb
remov
unbound
viru
ad
cell
incub
indic
length
time
h
controlexosom
prepar
cell
contain
vector
plasmid
without
express
cassett
quantifi
supernat
deriv
cell
treat
use
enzym
link
immunosorb
assay
elisa
kit
accord
manufactur
instruct
keygen
biotech
china
pbl
interferon
sourc
piscataway
nj
respect
follow
prelysi
treatment
trypsin
remov
adher
exosom
infect
cell
cultur
medium
harvest
variou
time
infect
subject
rna
extract
amount
dengu
viral
rna
measur
use
quantit
rel
realtim
rtpcr
assay
cpe
reduct
assay
h
post
infect
microscop
examin
perform
determin
antivir
effect
data
confirm
use
cell
viabil
assay
viabil
cell
measur
use
mt
assay
accord
manufactur
instruct
briefli
mt
solut
celltit
one
solut
reagent
promega
madison
wi
ad
well
incub
addit
h
absorb
subsequ
measur
nm
use
micropl
reader
biotek
winooski
vt
cell
treat
controlexosom
use
control
group
cell
growth
inhibit
rate
determin
use
follow
formula
accord
previous
publish
method
muhamad
et
al
cell
viabil
treat
control
cell
experi
repeat
least
three
time
mean
standard
deviat
sd
valu
calcul
data
given
text
present
mean
sd
comparison
two
group
evalu
student
test
use
cutoff
pvalu
correl
determin
exponenti
regress
analysi
use
ibm
spss
statist
softwar
addit
support
inform
may
found
onlin
version
articl
publish
websit
fig
ifitm
protein
famili
restrict
infect
entri
hela
c
cell
transduc
express
protein
control
vector
alon
verifi
western
blot
analysi
ifitm
protein
express
cell
measur
western
blot
analysi
use
aliquot
cell
assay
e
respect
actin
includ
load
control
cell
detect
use
monoclon
antibodi
direct
envelop
e
glycoprotein
viru
number
b
hela
f
cell
determin
flow
cytometri
fig
requir
antivir
effect
interferon
silenc
enhanc
infect
huvec
cell
transfect
indic
sirna
nontarget
control
sirna
sinc
assess
level
western
blot
analysi
h
post
transfect
indic
sirna
percentag
infect
cell
assess
h
viru
addit
flow
cytometri
e
protein
b
hela
cell
transfect
indic
sirna
control
nontarget
sirna
h
post
transfect
cell
incub
iu
ml
h
level
examin
western
blot
c
hela
cell
transfect
indic
sirna
incub
indic
concentr
h
h
post
transfect
follow
infect
moi
percentag
infect
cell
assess
h
viru
addit
flow
cytometri
denv
e
protein
e
effect
sirna
silenc
bind
entri
hela
cell
data
point
present
mean
sd
triplic
experi
student
twotail
test
perform
statist
differ
shown
asterisk
p
fig
mass
spectrometr
analysi
peptid
result
automat
gener
mass
spectromet
briefli
purifi
exosom
deriv
cell
overexpress
assay
massspectrometr
analysi
proteolyt
peptid
red
vertic
line
repres
peptid
ion
intens
horizont
axi
show
masstocharg
mz
valu
around
peptid
ion
interest
green
dash
line
automat
given
spectromet
point
label
red
peak
fig
cellderiv
exosom
chang
quantiti
recipi
hela
cell
compar
celland
cellderiv
exosom
fig
halflif
cell
cultur
supernat
level
protein
cell
cultur
supernat
huvec
variou
time
h
assay
western
blot
briefli
supernat
deriv
huvec
cell
collect
centrifug
g
min
centrifug
g
min
remov
cell
cell
debri
follow
filtrat
filter
obtain
supernat
concentr
use
amicon
centrifug
filter
unit
kda
cutoff
valu
divid
group
incub
humidifi
atmospher
h
respect
subject
western
blot
analysi
use
antibodi
intens
band
interest
pvdf
membran
quantit
calcul
quantiti
one
measur
softwar
result
present
rel
ratio
intens
band
h
treatment
group
fig
immunofluoresc
stain
confoc
microscop
analysi
viral
e
protein
hela
cell
treat
follow
infect
tabl
primer
sequenc
sirna
oligonucleatid
